Can GLP‑1 Injections Cause Muscle Loss? A Smarter, Science-Backed Alternative

By David Roberts, MPH — Co-founder, Mara Labs | Johns Hopkins Bloomberg School of Public Health

IGLP-1 drugs like semaglutide and tirzepatide produce significant weight loss, but emerging research shows that 15–40% of what comes off is lean mass, including skeletal muscle. That can make your clothes looser in the short term while leaving your metabolism weaker, your body more fragile, and long-term weight management harder.

This post unpacks the muscle-loss side of rapid GLP-1–driven weight changes and explores a slower, metabolism-first approach that works with your body's own systems, featuring GLPerfect with bioavailable berberine, ALA, and EGCG.

Does Rapid Weight Loss on GLP-1 Drugs Cause Muscle Loss?

GLP‑1 receptor agonists (like semaglutide and tirzepatide) were developed to lower blood sugar and improve cardiometabolic outcomes, and they are highly effective at producing large, rapid changes on the scale. But mounting data show that a meaningful chunk of that loss is lean tissue:

• Meta‑analyses and cohort studies report that 15–40% of the total weight lost on GLP‑1–based therapies is lean body mass, not fat.
• Some trials report that lean mass accounts for about one‑quarter to more than one‑third of the overall loss over 36+ weeks of GLP‑1 treatment.

For a person who drops 40 pounds, that can translate into 6–16 pounds of lean tissue, including skeletal muscle. That matters because muscle is not just “for looks”; it is:

• A primary driver of resting energy expenditure
• A reservoir for glucose disposal and insulin sensitivity
• Critical for balance, strength, and independence with aging

Reviews now specifically link GLP‑1 therapy with increased concern about sarcopenia, especially in older adults and those already at risk for low muscle mass. You can be “lighter” on the scale, but metabolically and functionally more vulnerable. This will eventually lead to "heavier" on the scale.

How Fast Should You Actually Be Losing Weight?

Major public‑health and clinical resources emphasize that slower, steady change is usually healthier and more sustainable:

• Many guidelines and expert reviews consider about 0.5–2 pounds per week a reasonable, sustainable pace, with around 1 pound per week often cited as a practical target for most people.

This pace allows:

• Hormones (insulin, leptin, ghrelin, thyroid) to adapt
• Connective tissue and joints to keep up
• Better preservation of lean mass, especially if resistance training and protein intake are in place

By contrast, GLP‑1 therapies often produce double‑digit percent changes in total body weight over months, far exceeding typical “healthy pace” guidance. Faster is not automatically better if a disproportionate slice is coming from muscle and if underlying metabolic issues remain unresolved.

What Is Really Driving Stubborn Weight Gain?

Whether or not you use a GLP‑1 drug, the deeper “why” behind stubborn body composition is usually metabolic and hormonal, not moral:

• Insulin resistance: Cells respond poorly to insulin, so the pancreas secretes more. Chronically high insulin pushes more fuel toward storage, limits fat mobilization, and contributes to leptin resistance.
• Leptin resistance: Leptin, produced by fat tissue, should signal “we have enough fuel, you can stop eating,” but in chronic overnutrition, the brain often ignores that signal. The result is persistent hunger despite high energy stores.
• Ghrelin dysregulation: Ghrelin, the “I’m hungry” hormone, often surges with sleep loss, stress, and aggressive restriction, driving rebound eating and cravings.
• Blunted endogenous GLP‑1 and gut hormones: Ultra‑processed diets, erratic eating, and low fiber can flatten natural GLP‑1 and PYY responses, making satiety harder to achieve without high doses of GLP‑1 medications.

GLP‑1 injections partially override this system from the outside by dramatically increasing GLP‑1 signaling, so you feel less hungry and eat less. But when the injection stops, the underlying insulin resistance, leptin resistance, and ghrelin dynamics often remain, waiting to reveal themselves as soon as you stop the injections.

A more sustainable strategy supports your own insulin and hunger‑hormone systems -helping them work in your favor instead of outsourcing them to a drug indefinitely.

What Is GLPerfect and How Does It Protect Muscle During Weight Loss?

GLPerfect from Mara Labs is formulated around that premise: healthy weight management should focus on metabolic health, appetite regulation, and muscle protection, not just rapid scale changes. It combines:

• Bioavailable berberine
• Alpha lipoic acid (ALA)
• EGCG (epigallocatechin gallate) from green tea

Together, these target insulin resistance, hunger signaling, fat metabolism, and muscle‑protective pathways like myostatin and PGC‑1α.

1. How Does Berberine Support Muscle and Insulin Sensitivity?

Berberine is a botanical alkaloid with a strong track record for improving glucose and lipid metabolism through activation of AMPK in the liver and muscle. In human and animal research, berberine:

• Lowers fasting glucose and improves post‑prandial control
• Increases insulin sensitivity and GLUT4‑mediated glucose uptake in skeletal muscle
• Favors a shift from fat storage toward fat use over time

Critically for muscle, berberine also impacts myostatin, a negative regulator of muscle growth:

• In insulin‑resistant and obesity‑related models, berberine down‑regulates myostatin expression, improves muscle fiber size, and facilitates metabolic remodeling of skeletal muscle.
• It engages AMPK/SIRT1/PGC‑1α and Smad pathways linked to better mitochondrial function and reduced sarcopenia risk.

That profile is almost the inverse of unchecked GLP‑1–driven rapid loss: berberine aims to improve metabolic terrain and support muscle rather than letting lean tissue erode as collateral damage.

2. What Does Alpha Lipoic Acid Do for Muscle and Blood Sugar?

ALA is a unique antioxidant and mitochondrial cofactor that:

• Enhances insulin‑stimulated glucose uptake in skeletal muscle, improving glycemic control without requiring extreme intake reductions.
• In type 2 diabetic animal models, it preserves skeletal muscle mass and fiber cross‑sectional area, reducing markers of oxidative damage and inflammation in muscle tissue.

By helping muscles act as a more effective sink for glucose, ALA can:

• Reduce the chronic high‑insulin environment that drives fat storage and leptin resistance
• Support muscle energy production and resilience, which is critical if you’re also engaging in resistance training

In the context of healthy weight management, that means better carb handling and energy while protecting the very tissue you want to keep.

3. How Does EGCG Support Fat Loss Without Muscle Loss?

EGCG from green tea brings in appetite and fat‑metabolism support:

• Green tea catechins increase fat oxidation and energy expenditure and may modestly reduce body fat in humans, especially when combined with movement and caloric control.
• EGCG and related compounds modulate central and gut pathways involved in appetite and food reward and can support healthier leptin and ghrelin signaling in the context of lifestyle changes.

On the muscle side:

• Experimental work shows that EGCG can stimulate myogenic differentiation and modulate myostatin/TGF‑β–related pathways, which aligns with improved muscle development and repair.

So EGCG helps on both sides of the equation: less compulsion to overeat and better support for muscle tissue rather than neglecting it.